Medtronic PLC said fiscal third-quarter 2018 earnings per share rose 4% year over year.

The Dublin-based medical device company reported non-GAAP net income of $1.59 billion, or $1.17 per share, for the quarter that ended Jan. 26, up from $1.55 billion, or $1.12 per share, a year earlier.

The S&P Capital IQ normalized EPS consensus estimate for the third quarter was $1.17.

Medtronic booked total quarterly revenues of $7.37 billion, up 7% year over year on a constant currency basis.

On a GAAP basis, Medtronic posted a net loss of $1.39 billion, or $1.03 per share, compared to a net income of $821 million, or 59 cents per share, in the comparable, year-ago fiscal quarter.